CHUGAI PHARMACEUTICAL CO., LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,921 JPY | -3.32% |
|
-6.03% | -7.88% |
| Apr. 10 | Japan's Nikkei slips on caution ahead of US inflation data | RE |
| Mar. 29 | Chugai Pharmaceutical to Allocate 594 Million Yen of Treasury Shares as Restricted Stock Compensation | MT |
| Sales 2024 * | 1,093B 7.08B | Sales 2025 * | 1,138B 7.37B | Capitalization | 8,375B 54.23B |
|---|---|---|---|---|---|
| Net income 2024 * | 344B 2.23B | Net income 2025 * | 368B 2.39B | EV / Sales 2024 * | 6.93 x |
| Net cash position 2024 * | 801B 5.19B | Net cash position 2025 * | 1,002B 6.49B | EV / Sales 2025 * | 6.48 x |
| P/E ratio 2024 * |
24.4
x | P/E ratio 2025 * |
22.8
x | Employees | 7,604 |
| Yield 2024 * |
1.67% | Yield 2025 * |
1.77% | Free-Float | 38.08% |
More Fundamentals
* Assessed data
More news
Latest transcript on Chugai Pharmaceutical Co., Ltd
More recommendations
More press releases
| 1 day | -3.32% | ||
| 1 week | -6.03% | ||
| Current month | -14.77% | ||
| 1 month | -18.80% | ||
| 3 months | -11.19% | ||
| 6 months | +6.68% | ||
| Current year | -7.88% |
1 week
4 896.00
5 155.00
1 month
4 896.006 153.00
Current year
4 896.006 697.00
1 year
3 241.006 697.00
3 years
3 191.006 697.00
5 years
2 250.006 697.00
10 years
833.676 697.00
| Managers | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 61 | 87-03-31 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 79 | 15-02-28 |
Motoo Ueno
BRD | Director/Board Member | 66 | 84-03-31 |
James H. Sabry
BRD | Director/Board Member | 65 | 19-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.57% | 15 M€ | +4.29% | ||
| 1.87% | 60 M€ | +11.67% | ||
| 1.59% | 4 M€ | +12.04% | ||
| 1.53% | 67,864 M€ | +11.66% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 4,921 | -3.32% | 3 141 300 |
| 24-04-18 | 5,090 | +0.49% | 2,472,600 |
| 24-04-17 | 5,065 | -1.29% | 2,022,700 |
| 24-04-16 | 5,131 | +0.51% | 2,484,100 |
| 24-04-15 | 5,105 | -2.52% | 2,078,300 |
Delayed Quote Japan Exchange, April 19, 2024 at 02:00 am EDT
More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
2024-04-24
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
5,090
JPY
Average target price
6,090
JPY
Spread / Average Target
+19.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.88% | 54.17B | |
| +27.97% | 672B | |
| +23.46% | 550B | |
| -7.02% | 351B | |
| +14.85% | 317B | |
| +6.25% | 292B | |
| +2.40% | 211B | |
| -0.88% | 203B | |
| -10.18% | 194B | |
| -11.81% | 144B |
- Stock Market
- Equities
- 4519 Stock
